CanBas Co. Ltd.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer (NCT04953962) | CanBas Co. Ltd. | 2021-12-18 |
| CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors (NCT03113188) | CanBas Co. Ltd. | 2017-10-25 |
Track CanBas Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.